Ocaliva Approved for Rare Liver Disease

TUESDAY, May 31, 2016 — Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis (PBC).
The disease causes the liver’s small bile ducts to become…
Source: Topamax